Cargando…

Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder

The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Imataka, George, Yui, Kunio, Shiko, Yuki, Kawasaki, Yohei, Sasaki, Hitomi, Shiroki, Ryoichi, Yoshihara, Shigemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446379/
https://www.ncbi.nlm.nih.gov/pubmed/34539458
http://dx.doi.org/10.3389/fpsyt.2021.684445
_version_ 1784568857573195776
author Imataka, George
Yui, Kunio
Shiko, Yuki
Kawasaki, Yohei
Sasaki, Hitomi
Shiroki, Ryoichi
Yoshihara, Shigemi
author_facet Imataka, George
Yui, Kunio
Shiko, Yuki
Kawasaki, Yohei
Sasaki, Hitomi
Shiroki, Ryoichi
Yoshihara, Shigemi
author_sort Imataka, George
collection PubMed
description The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers, (1) hexanoyl-lysine (HEL), which is a new biomarker of oxidative stress, (2) the total antioxidant capacity (TAC), and (3) 8-hydroxy-2′-deoxyguanosine (8-OHdG), as a product of oxidative modifications to DNA; and the plasma levels of (4) the antioxidant protein superoxide dismutase (SOD), which is the crucial defense again oxygen reactive species, and (5) transferrin and (6) ceruloplasmin, which are biomarkers of iron and copper neurotransmission and oxidant-antioxidant systems. We examined the relationship between these urinary and plasma biomarkers and behavioral symptoms in 19 individuals with ASD (mean age, 10.8 ± 5.2 years) and 10 age-matched healthy controls (mean age, 14.2 ± 7.0 years). Behavioral symptoms were estimated using the Aberrant Behavior Checklist (ABC). Urinary TAC levels were significantly lower, whereas urinary HEL levels were significantly increased in the ASD group as compared with the control group. The five ABC subscale and total scores were significantly raised in the autism group than in the control group. The results of a linear regression analysis revealed that plasma SOD levels may be a more accurate predictor of differences in ABC scores between individuals with ASD and control individuals. The present study firstly revealed the important findings that the cooperation between the urinary antioxidant TAC and plasma SOD levels may contribute to the ABC subscale scores of stereotypy. Urinary TAC activity and antioxidant protein SOD may be associated with incomplete mineral body store and antioxidant-related transcription factor and browning reactions. Consequently, a critical imbalance between TAC urinary levels and plasma SOD levels may be an important contributor to autistic behavioral symptoms.
format Online
Article
Text
id pubmed-8446379
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84463792021-09-18 Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder Imataka, George Yui, Kunio Shiko, Yuki Kawasaki, Yohei Sasaki, Hitomi Shiroki, Ryoichi Yoshihara, Shigemi Front Psychiatry Psychiatry The balance between antioxidant capacity and oxidative stress-induced free radicals may be crucial in the pathophysiological development factor of autism spectrum disorder (ASD). We measured the following urinary and plasma biomarker levels of oxidative stress and antioxidants. As urinary biomarkers, (1) hexanoyl-lysine (HEL), which is a new biomarker of oxidative stress, (2) the total antioxidant capacity (TAC), and (3) 8-hydroxy-2′-deoxyguanosine (8-OHdG), as a product of oxidative modifications to DNA; and the plasma levels of (4) the antioxidant protein superoxide dismutase (SOD), which is the crucial defense again oxygen reactive species, and (5) transferrin and (6) ceruloplasmin, which are biomarkers of iron and copper neurotransmission and oxidant-antioxidant systems. We examined the relationship between these urinary and plasma biomarkers and behavioral symptoms in 19 individuals with ASD (mean age, 10.8 ± 5.2 years) and 10 age-matched healthy controls (mean age, 14.2 ± 7.0 years). Behavioral symptoms were estimated using the Aberrant Behavior Checklist (ABC). Urinary TAC levels were significantly lower, whereas urinary HEL levels were significantly increased in the ASD group as compared with the control group. The five ABC subscale and total scores were significantly raised in the autism group than in the control group. The results of a linear regression analysis revealed that plasma SOD levels may be a more accurate predictor of differences in ABC scores between individuals with ASD and control individuals. The present study firstly revealed the important findings that the cooperation between the urinary antioxidant TAC and plasma SOD levels may contribute to the ABC subscale scores of stereotypy. Urinary TAC activity and antioxidant protein SOD may be associated with incomplete mineral body store and antioxidant-related transcription factor and browning reactions. Consequently, a critical imbalance between TAC urinary levels and plasma SOD levels may be an important contributor to autistic behavioral symptoms. Frontiers Media S.A. 2021-09-03 /pmc/articles/PMC8446379/ /pubmed/34539458 http://dx.doi.org/10.3389/fpsyt.2021.684445 Text en Copyright © 2021 Imataka, Yui, Shiko, Kawasaki, Sasaki, Shiroki and Yoshihara. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Imataka, George
Yui, Kunio
Shiko, Yuki
Kawasaki, Yohei
Sasaki, Hitomi
Shiroki, Ryoichi
Yoshihara, Shigemi
Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
title Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
title_full Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
title_fullStr Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
title_full_unstemmed Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
title_short Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
title_sort urinary and plasma antioxidants in behavioral symptoms of individuals with autism spectrum disorder
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446379/
https://www.ncbi.nlm.nih.gov/pubmed/34539458
http://dx.doi.org/10.3389/fpsyt.2021.684445
work_keys_str_mv AT imatakageorge urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder
AT yuikunio urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder
AT shikoyuki urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder
AT kawasakiyohei urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder
AT sasakihitomi urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder
AT shirokiryoichi urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder
AT yoshiharashigemi urinaryandplasmaantioxidantsinbehavioralsymptomsofindividualswithautismspectrumdisorder